Healthtech firm Accolade is buying telemedicine start-up 2nd.MD for $460 million, sources say

Raj Singh, chief executive officer of Accolade speaks during the GeekWire Summit event in Seattle, Washington, Oct. 3, 2018. David Ryder | Bloomberg | Getty Images Accolade, a health care technology company that helps employees navigate their medical plans, is buying telemedicine start-up 2nd.MD to bolster its ability to provide users with second opinions, CNBC has learned exclusively. Accolade is close to announcing the acquisition of Houston-based Innovation Specialists, parent company of 2nd.MD, for about $460 million, according to people with knowledge of the situation. The transaction will be half…